Sailer Carl 4
4 · Acurx Pharmaceuticals, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Sailer Carl
Director
Transactions
- Exercise/Conversion
Common Stock
2024-01-19$3.55/sh+19,737$70,066→ 112,552 total - Exercise/Conversion
Warrants for Common Stock
2024-01-19−19,737→ 0 totalExercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying)
Holdings
- 5,000(indirect: By Spouse)
Common Stock